(C) PLOS One [1]. This unaltered content originally appeared in journals.plosone.org.
Licensed under Creative Commons Attribution (CC BY) license.
url:https://journals.plos.org/plosone/s/licenses-and-copyright

------------



Initiatives to address leprosy as a human rights issue through the mandate of UN Special Rapporteur: Achievements and challenges

['Takahiro Nanri', 'Sasakawa Health Foundation', 'Tokyo']

Date: 2022-05

Leprosy, or Hansen’s disease, is one of the oldest infectious diseases in the world. It has long been associated with stigma and discrimination, but only in recent years has this aspect been formally recognized by the international community as a human rights issue. The UN Human Rights Council first adopted a resolution on leprosy in 2008, and this was later followed by a UN General Assembly resolution in 2010. Nonbinding principle and guidelines on elimination of discrimination against persons affected by leprosy and their family members accompanied the 2010 resolution, but these have yet to be fully implemented. In 2017, the Human Rights Council appointed a Special Rapporteur on leprosy to investigate the extent to which the principles and guidelines have been implemented, and her term was extended for a further 3 years in 2020. Considering the proper implementation of the principles and guidelines to be key to eliminating the discrimination that persons affected by leprosy and their families face in various parts of the world, this paper looks at the contribution the Special Rapporteur can make. Based on an assessment of her activities to date, it concludes that the Special Rapporteur has actively worked to build networks with persons affected by leprosy and related organizations and gain their trust, but has faced challenges in organizing official country visits. It goes on to analyze what sort of legacy the Special Rapporteur should aim to leave behind after completing her second term and how she can go about doing so in the time remaining. To this end, it makes 5 suggestions: (1) gather information systematically on the actual situation of discrimination; (2) compile a collection of success stories; (3) ensure that there is consistency between legally binding international covenants and treaties and the principles and guidelines; (4) present proposals for concrete actions that can be taken after the Special Rapporteur’s second term ends; and (5) initiate a feasibility study on creating an “index” and “indicators” to measure the current status of stigma and discrimination and the extent to which the principles and guidelines have been implemented.

Copyright: © 2022 Takahiro Nanri. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Introduction

Leprosy, also known as Hansen’s disease, is an infectious disease caused by the bacillus Mycobacterium leprae. Once incurable, leprosy is now treatable with multidrug therapy (MDT). But if treatment is delayed, the disease, which mainly affects the skin and peripheral nerves, can result in lifelong disability. Despite medical advances, outdated notions of the disease persist, meaning that persons who have been cured and even their family members face severe discrimination. For example, the World Health Organization (WHO) states that one or more instances of discrimination were reported in 51 countries in 2020 [1]. In addition, according to data compiled by the International Federation of Anti-Leprosy Associations (ILEP), there are 139 discriminatory laws associated with leprosy at least in 24 countries [2].

Why does such discrimination still exist? Without cure for much of its long history, leprosy’s progressively disfiguring effects fears that it was highly contagious or even that it was divine punishment shaped perceptions of the disease. Second, after Norwegian doctor Gerhard Armauer Hansen’s discovery of M. leprae revealed leprosy to be an infectious disease caused by a bacillus, the introduction of compulsory segregation in various parts of the world reinforced the idea that already existed that people with leprosy were to be excluded from society, an image that has lingered in people’s minds.

Therefore, a “social” as well as a “medical” approach is essential in dealing with leprosy. Based on this, WHO has recently issued its “Global Leprosy Strategy 2021–2030” [3], which sets “Combat stigma and ensure human rights” as one of the 4 pillars. This means that all those who engage in leprosy services at any stages, be they doctors or health workers, are required to pay attention not only to the care of disease and disabilities but also to the problems of stigma and discrimination that persons affected by leprosy encounter.

Only recently leprosy has been formally recognized by the international community as a human rights issue. The United Nations Human Rights Council (UNHRC) first adopted a resolution on “Elimination of discrimination against persons affected by leprosy and their family members” in 2008. In 2010, the United Nations General Assembly unanimously approved its own resolution, which noted with appreciation principles and guidelines for the elimination of discrimination against persons affected by leprosy and their family members that provide governments with a roadmap on how to address the issue. More recently, the UNHRC appointed a United Nations Special Rapporteur on the elimination of discrimination against persons affected by leprosy and their family members in September 2017 for a 3-year term, and, in July 2020, her term was extended by 3 years.

Shigeki Sakamoto, who drafted the principles and guidelines as a member of the Advisory Committee of the UNHRC, described the document’s significance as follows: “First, international standards of human rights have been established for persons affected by leprosy. Second, it clarifies that persons affected by leprosy are entitled to human rights under international law [4].” However, since governments are not forced to comply with them, the issue is how the principles and guidelines will actually be implemented and how they will bring an end to leprosy-related discrimination.

Activities of the UN Special Rapporteur on leprosy The Special Rapporteur has submitted annual thematic reports to the UNHRC since 2018. In her first report [12], she noted that discrimination related to leprosy still exists at the macro level of national policy and laws, at the micro level of community and family, and in between within institutions and organizations (relating to health, education, employment, etc.). The report stressed that, in order to eliminate such structural discrimination, it is important to involve those affected by the disease. In her 2019 report focusing on “wrongful stereotyping and structural violence against women and children affected by leprosy [13],” she at first raises the issue of the lack of reliable data on how stereotypes and practices impact the lives of persons affected by leprosy. Then she emphasizes how persons affected have historically been “dehumanized.” The theme of the 2020 report is a “Policy framework for rights-based action plans [14],” and the report lists a number of initiatives as a final recommendation, including the following: (1) respect the rights of persons affected; (2) ensure the participation of persons affected and create a system of governance to guarantee it; (3) collect data on the actual situation of discrimination; (4) construct monitoring systems for human rights violations; (5) allocate an appropriate budget at the national and state level; (6) promote international cooperation; and (7) pursue initiatives linked to the sustainable development goals. In her latest thematic report submitted to the UNHRC in 2021, the Special Rapporteur focuses on the disproportionate impact of COVID-19 on persons affected by leprosy and their family members [15]. According to the report, persons affected by leprosy, who have already been excluded from society, are severely impacted by COVID-19 and face various problems, including unemployment, loss of livelihoods, and difficulty in accessing existing safety nets. Taking into account the fact that persons affected are among society’s most vulnerable members, she recommends that governments should immediately take both short- and medium-term measures to respond to the situation.

Achievements and challenges One of the Special Rapporteur’s achievements to date is the way she has built links with persons affected by leprosy and related organizations around the world and gained their trust. Furthermore, the presence of the Special Rapporteur is encouraging networking among persons affected by leprosy to progress and is also contributing to their empowerment. On the other hand, there have also been challenges. During her first term, the Special Rapporteur was scheduled to make 6 official country visits in 3 years, but only realized visits to 2 target countries, Brazil and Japan, which remains the case to date. One can speculate as to the reasons: (1) many governmental officials do not see leprosy as a human rights issue; (2) the Office of the High Commissioner for Human Rights has not prioritized leprosy compared to other human rights issues, and its support for the Special Rapporteur has been insufficient; (3) the global leprosy community is relatively small and not influential enough to exert pressure on target countries to accept visits; (4) initial approaches to target countries got off to a slow start because this was a newly established mandate; and (5) the coronavirus pandemic that took hold in the latter stages of the Special Rapporteur’s term made country visits impossible.

[END]

[1] Url: https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0010201

(C) Plos One. "Accelerating the publication of peer-reviewed science."
Licensed under Creative Commons Attribution (CC BY 4.0)
URL: https://creativecommons.org/licenses/by/4.0/


via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/plosone/